Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.
作者信息
Paolino Giovanni, Di Nicola Matteo Riccardo, Cantisani Carmen, Mercuri Santo Raffaele
机构信息
Unit of Dermatology, IRCCS San Raffaele Hospital, Milan, Italy.
Dermatologic Clinic, Sapienza University of Rome, Rome, Italy.
出版信息
Dermatol Ther. 2021 Jul;34(4):e14972. doi: 10.1111/dth.14972. Epub 2021 May 24.
Abstract
摘要
相似文献
1
Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.
Dermatol Ther. 2021 Jul;34(4):e14972. doi: 10.1111/dth.14972. Epub 2021 May 24.
2
Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
Medicine (Baltimore). 2021 Apr 9;100(14):e25352. doi: 10.1097/MD.0000000000025352.
3
Pityriasis rosea after mRNA COVID-19 vaccination.
Int J Dermatol. 2021 Sep;60(9):1150-1151. doi: 10.1111/ijd.15700. Epub 2021 Jun 10.
4
Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
J Cosmet Dermatol. 2021 Oct;20(10):3080-3084. doi: 10.1111/jocd.14372. Epub 2021 Aug 7.
5
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
6
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.
7
Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e491-e493. doi: 10.1111/jdv.17316. Epub 2021 May 10.
8
Pityriasis Rosea as a Possible Complication of Vaccination Against COVID-19.
Dtsch Arztebl Int. 2021 Jun 25;118(25):431. doi: 10.3238/arztebl.m2021.0257.
9
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
10
Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e489-e491. doi: 10.1111/jdv.17301. Epub 2021 May 12.
引用本文的文献
1
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea.
Am J Clin Dermatol. 2025 Mar;26(2):237-250. doi: 10.1007/s40257-024-00915-7. Epub 2025 Jan 11.
2
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
3
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
4
Cutaneous Reactions to COVID-19 Vaccines in a Monocentric Study: A Case Series.
J Clin Med. 2022 Jun 30;11(13):3811. doi: 10.3390/jcm11133811.
5
Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
J Dermatol. 2022 Oct;49(10):948-956. doi: 10.1111/1346-8138.16482. Epub 2022 Jun 8.
本文引用的文献
1
Pityriasis rosea as a leading manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2021 Apr;35(4):e246-e247. doi: 10.1111/jdv.17052. Epub 2020 Dec 23.
2
Pityriasis rosea-like eruption revealing COVID-19.
Australas J Dermatol. 2021 May;62(2):e333-e334. doi: 10.1111/ajd.13504. Epub 2020 Nov 20.
3
Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases.
JAAD Case Rep. 2021 Jan;7:93-94. doi: 10.1016/j.jdcr.2020.10.035. Epub 2020 Nov 7.
4
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
5
Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19.
Med Clin (Engl Ed). 2020 Sep 25;155(6):273. doi: 10.1016/j.medcle.2020.05.017. Epub 2020 Sep 4.
6
Prolonged dermatological manifestation 4 weeks following recovery of COVID-19 in a child.
BMJ Case Rep. 2020 Aug 11;13(8):e237056. doi: 10.1136/bcr-2020-237056.
7
The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dermatol Ther. 2020 Jul;33(4):e13730. doi: 10.1111/dth.13730. Epub 2020 Jun 29.
8
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437. doi: 10.1111/jdv.16579. Epub 2020 Jun 11.
Zotero 插件